APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liquid Embolic Agent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liquid Embolic Agent Market Analysis and Forecast 2026-2032

5 July 2026197 pages

Choose your research edition.

Industry ResearchLiquid Embolic Agent Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Liquid Embolic Agent Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Liquid Embolic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liquid Embolic Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Liquid Embolic Agent Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Liquid Embolic Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liquid Embolic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liquid Embolic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liquid Embolic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liquid Embolic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liquid Embolic Agent include Saikesaisi Holding, Johnson & Johnson, Medtronic, Meril Life, BlackSwan Vascular and Balt Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liquid Embolic Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liquid Embolic Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Liquid Embolic Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liquid Embolic Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liquid Embolic Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liquid Embolic Agent sales, projected growth trends, production technology, application and end-user industry.

Liquid Embolic Agent Segment by Company

Saikesaisi Holding

Johnson & Johnson

Medtronic

Meril Life

BlackSwan Vascular

Balt Group

Liquid Embolic Agent Segment by Type

EVOH Type

nBCA Type

Other

Liquid Embolic Agent Segment by Application

Cerebral Arteriovenous Malformations (AVMs)

Dural Arteriovenous Fistulas (DAVFs)

Other

Liquid Embolic Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Embolic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liquid Embolic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Embolic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liquid Embolic Agent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liquid Embolic Agent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liquid Embolic Agent sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liquid Embolic Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. EVOH Type Major Manufacturers Table 3. nBCA Type Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Liquid Embolic Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cerebral Arteriovenous Malformations (AVMs) Major Manufacturers Table 7. Dural Arteriovenous Fistulas (DAVFs) Major Manufacturers Table 8. Other Major Manufacturers Table 9. Liquid Embolic Agent Industry Trends Table 10. Liquid Embolic Agent Industry Drivers Table 11. Liquid Embolic Agent Industry Opportunities and Challenges Table 12. Liquid Embolic Agent Industry Restraints Table 13. Global Liquid Embolic Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Liquid Embolic Agent Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Liquid Embolic Agent Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Liquid Embolic Agent Revenue Market Share by Region (2021-2026) Table 17. Global Liquid Embolic Agent Revenue Market Share by Region (2027-2032) Table 18. Global Liquid Embolic Agent Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Liquid Embolic Agent Sales by Region (2021-2026) & (k units) Table 20. Global Liquid Embolic Agent Sales by Region (2027-2032) & (k units) Table 21. Global Liquid Embolic Agent Sales Market Share by Region (2021-2026) Table 22. Global Liquid Embolic Agent Sales Market Share by Region (2027-2032) Table 23. Global Liquid Embolic Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Liquid Embolic Agent Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Liquid Embolic Agent Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Liquid Embolic Agent Sales Market Share by Manufacturers (2021-2026) Table 27. Global Liquid Embolic Agent Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Liquid Embolic Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Liquid Embolic Agent Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Liquid Embolic Agent Manufacturers, Product Type & Application Table 31. Global Liquid Embolic Agent Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Liquid Embolic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Liquid Embolic Agent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Liquid Embolic Agent Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Liquid Embolic Agent Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Liquid Embolic Agent Revenue Market Share by Type (2021-2026) Table 38. Global Liquid Embolic Agent Revenue Market Share by Type (2027-2032) Table 39. Global Liquid Embolic Agent Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Liquid Embolic Agent Sales by Type (2021-2026) & (k units) Table 41. Global Liquid Embolic Agent Sales by Type (2027-2032) & (k units) Table 42. Global Liquid Embolic Agent Sales Market Share by Type (2021-2026) Table 43. Global Liquid Embolic Agent Sales Market Share by Type (2027-2032) Table 44. Global Liquid Embolic Agent Price by Type (2021-2026) & (USD/unit) Table 45. Global Liquid Embolic Agent Price by Type (2027-2032) & (USD/unit) Table 46. Global Liquid Embolic Agent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Liquid Embolic Agent Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Liquid Embolic Agent Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Liquid Embolic Agent Revenue Market Share by Application (2021-2026) Table 50. Global Liquid Embolic Agent Revenue Market Share by Application (2027-2032) Table 51. Global Liquid Embolic Agent Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Liquid Embolic Agent Sales by Application (2021-2026) & (k units) Table 53. Global Liquid Embolic Agent Sales by Application (2027-2032) & (k units) Table 54. Global Liquid Embolic Agent Sales Market Share by Application (2021-2026) Table 55. Global Liquid Embolic Agent Sales Market Share by Application (2027-2032) Table 56. Global Liquid Embolic Agent Price by Application (2021-2026) & (USD/unit) Table 57. Global Liquid Embolic Agent Price by Application (2027-2032) & (USD/unit) Table 58. Saikesaisi Holding Company Information Table 59. Saikesaisi Holding Business Overview Table 60. Saikesaisi Holding Liquid Embolic Agent Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Saikesaisi Holding Liquid Embolic Agent Product Portfolio Table 62. Saikesaisi Holding Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Liquid Embolic Agent Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Liquid Embolic Agent Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Medtronic Company Information Table 69. Medtronic Business Overview Table 70. Medtronic Liquid Embolic Agent Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Medtronic Liquid Embolic Agent Product Portfolio Table 72. Medtronic Recent Development Table 73. Meril Life Company Information Table 74. Meril Life Business Overview Table 75. Meril Life Liquid Embolic Agent Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Meril Life Liquid Embolic Agent Product Portfolio Table 77. Meril Life Recent Development Table 78. BlackSwan Vascular Company Information Table 79. BlackSwan Vascular Business Overview Table 80. BlackSwan Vascular Liquid Embolic Agent Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. BlackSwan Vascular Liquid Embolic Agent Product Portfolio Table 82. BlackSwan Vascular Recent Development Table 83. Balt Group Company Information Table 84. Balt Group Business Overview Table 85. Balt Group Liquid Embolic Agent Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Balt Group Liquid Embolic Agent Product Portfolio Table 87. Balt Group Recent Development Table 88. North America Liquid Embolic Agent Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Liquid Embolic Agent Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Liquid Embolic Agent Sales by Type (2021-2026) & (k units) Table 91. North America Liquid Embolic Agent Sales by Type (2027-2032) & (k units) Table 92. North America Liquid Embolic Agent Sales Price by Type (2021-2026) & (USD/unit) Table 93. North America Liquid Embolic Agent Sales Price by Type (2027-2032) & (USD/unit) Table 94. North America Liquid Embolic Agent Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Liquid Embolic Agent Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Liquid Embolic Agent Sales by Application (2021-2026) & (k units) Table 97. North America Liquid Embolic Agent Sales by Application (2027-2032) & (k units) Table 98. North America Liquid Embolic Agent Sales Price by Application (2021-2026) & (USD/unit) Table 99. North America Liquid Embolic Agent Sales Price by Application (2027-2032) & (USD/unit) Table 100. North America Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Liquid Embolic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Liquid Embolic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 104. North America Liquid Embolic Agent Sales by Country (2021-2026) & (k units) Table 105. North America Liquid Embolic Agent Sales by Country (2027-2032) & (k units) Table 106. North America Liquid Embolic Agent Sales Price by Country (2021-2026) & (USD/unit) Table 107. North America Liquid Embolic Agent Sales Price by Country (2027-2032) & (USD/unit) Table 108. United States Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 109. Canada Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 110. Mexico Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 111. Europe Liquid Embolic Agent Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Liquid Embolic Agent Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Liquid Embolic Agent Sales by Type (2021-2026) & (k units) Table 114. Europe Liquid Embolic Agent Sales by Type (2027-2032) & (k units) Table 115. Europe Liquid Embolic Agent Sales Price by Type (2021-2026) & (USD/unit) Table 116. Europe Liquid Embolic Agent Sales Price by Type (2027-2032) & (USD/unit) Table 117. Europe Liquid Embolic Agent Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Liquid Embolic Agent Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Liquid Embolic Agent Sales by Application (2021-2026) & (k units) Table 120. Europe Liquid Embolic Agent Sales by Application (2027-2032) & (k units) Table 121. Europe Liquid Embolic Agent Sales Price by Application (2021-2026) & (USD/unit) Table 122. Europe Liquid Embolic Agent Sales Price by Application (2027-2032) & (USD/unit) Table 123. Europe Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Liquid Embolic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Liquid Embolic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 127. Europe Liquid Embolic Agent Sales by Country (2021-2026) & (k units) Table 128. Europe Liquid Embolic Agent Sales by Country (2027-2032) & (k units) Table 129. Europe Liquid Embolic Agent Sales Price by Country (2021-2026) & (USD/unit) Table 130. Europe Liquid Embolic Agent Sales Price by Country (2027-2032) & (USD/unit) Table 131. Germany Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 132. France Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 133. U.K. Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 134. Italy Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 135. Russia Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 136. Spain Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 137. Netherlands Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 138. Switzerland Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 139. Sweden Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 140. Poland Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 141. China Liquid Embolic Agent Revenue by Type (2021-2026) & (US$ Million) Table 142. China Liquid Embolic Agent Revenue by Type (2027-2032) & (US$ Million) Table 143. China Liquid Embolic Agent Sales by Type (2021-2026) & (k units) Table 144. China Liquid Embolic Agent Sales by Type (2027-2032) & (k units) Table 145. China Liquid Embolic Agent Sales Price by Type (2021-2026) & (USD/unit) Table 146. China Liquid Embolic Agent Sales Price by Type (2027-2032) & (USD/unit) Table 147. China Liquid Embolic Agent Revenue by Application (2021-2026) & (US$ Million) Table 148. China Liquid Embolic Agent Revenue by Application (2027-2032) & (US$ Million) Table 149. China Liquid Embolic Agent Sales by Application (2021-2026) & (k units) Table 150. China Liquid Embolic Agent Sales by Application (2027-2032) & (k units) Table 151. China Liquid Embolic Agent Sales Price by Application (2021-2026) & (USD/unit) Table 152. China Liquid Embolic Agent Sales Price by Application (2027-2032) & (USD/unit) Table 153. Asia Liquid Embolic Agent Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Liquid Embolic Agent Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Liquid Embolic Agent Sales by Type (2021-2026) & (k units) Table 156. Asia Liquid Embolic Agent Sales by Type (2027-2032) & (k units) Table 157. Asia Liquid Embolic Agent Sales Price by Type (2021-2026) & (USD/unit) Table 158. Asia Liquid Embolic Agent Sales Price by Type (2027-2032) & (USD/unit) Table 159. Asia Liquid Embolic Agent Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Liquid Embolic Agent Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Liquid Embolic Agent Sales by Application (2021-2026) & (k units) Table 162. Asia Liquid Embolic Agent Sales by Application (2027-2032) & (k units) Table 163. Asia Liquid Embolic Agent Sales Price by Application (2021-2026) & (USD/unit) Table 164. Asia Liquid Embolic Agent Sales Price by Application (2027-2032) & (USD/unit) Table 165. Asia Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Liquid Embolic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Liquid Embolic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. Asia Liquid Embolic Agent Sales by Country (2021-2026) & (k units) Table 170. Asia Liquid Embolic Agent Sales by Country (2027-2032) & (k units) Table 171. Asia Liquid Embolic Agent Sales Price by Country (2021-2026) & (USD/unit) Table 172. Asia Liquid Embolic Agent Sales Price by Country (2027-2032) & (USD/unit) Table 173. Japan Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 174. South Korea Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 175. India Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 176. Australia Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 177. Taiwan Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Liquid Embolic Agent Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Liquid Embolic Agent Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Liquid Embolic Agent Sales by Type (2021-2026) & (k units) Table 182. SAMEA Liquid Embolic Agent Sales by Type (2027-2032) & (k units) Table 183. SAMEA Liquid Embolic Agent Sales Price by Type (2021-2026) & (USD/unit) Table 184. SAMEA Liquid Embolic Agent Sales Price by Type (2027-2032) & (USD/unit) Table 185. SAMEA Liquid Embolic Agent Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Liquid Embolic Agent Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Liquid Embolic Agent Sales by Application (2021-2026) & (k units) Table 188. SAMEA Liquid Embolic Agent Sales by Application (2027-2032) & (k units) Table 189. SAMEA Liquid Embolic Agent Sales Price by Application (2021-2026) & (USD/unit) Table 190. SAMEA Liquid Embolic Agent Sales Price by Application (2027-2032) & (USD/unit) Table 191. SAMEA Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Liquid Embolic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Liquid Embolic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 195. SAMEA Liquid Embolic Agent Sales by Country (2021-2026) & (k units) Table 196. SAMEA Liquid Embolic Agent Sales by Country (2027-2032) & (k units) Table 197. SAMEA Liquid Embolic Agent Sales Price by Country (2021-2026) & (USD/unit) Table 198. SAMEA Liquid Embolic Agent Sales Price by Country (2027-2032) & (USD/unit) Table 199. Brazil Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 200. Argentina Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 201. Chile Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 202. Colombia Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 203. Peru Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 205. Israel Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 206. UAE Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 207. Turkey Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 208. Iran Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 209. Egypt Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Liquid Embolic Agent Distributors List Table 213. Liquid Embolic Agent Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Liquid Embolic Agent Image Figure 2. Global Liquid Embolic Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liquid Embolic Agent Market Size Share 2021 VS 2025 VS 2032 Figure 4. EVOH Type Image Figure 5. nBCA Type Image Figure 6. Other Image Figure 7. Global Liquid Embolic Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Liquid Embolic Agent Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cerebral Arteriovenous Malformations (AVMs) Image Figure 10. Dural Arteriovenous Fistulas (DAVFs) Image Figure 11. Other Image Figure 12. Global Liquid Embolic Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Liquid Embolic Agent Revenue (2021-2032) & (US$ Million) Figure 14. Global Liquid Embolic Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Liquid Embolic Agent Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Liquid Embolic Agent Revenue Market Share by Region (2021-2032) Figure 17. Global Liquid Embolic Agent Sales (2021-2032) & (k units) Figure 18. Global Liquid Embolic Agent Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Liquid Embolic Agent Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Liquid Embolic Agent Sales YoY (2021-2032) & (k units) Figure 21. Europe Liquid Embolic Agent Sales YoY (2021-2032) & (k units) Figure 22. China Liquid Embolic Agent Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Liquid Embolic Agent Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Liquid Embolic Agent Sales YoY (2021-2032) & (k units) Figure 25. Global Liquid Embolic Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Liquid Embolic Agent Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Liquid Embolic Agent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Liquid Embolic Agent Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Liquid Embolic Agent Revenue Market Share by Type (2021-2032) Figure 31. Global Liquid Embolic Agent Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Liquid Embolic Agent Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Liquid Embolic Agent Sales Market Share by Type (2021-2032) Figure 34. Global Liquid Embolic Agent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Liquid Embolic Agent Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Liquid Embolic Agent Revenue Market Share by Application (2021-2032) Figure 37. Global Liquid Embolic Agent Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Liquid Embolic Agent Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Liquid Embolic Agent Sales Market Share by Application (2021-2032) Figure 40. North America Liquid Embolic Agent Revenue Share by Type (2021-2032) Figure 41. North America Liquid Embolic Agent Sales Share by Type (2021-2032) Figure 42. North America Liquid Embolic Agent Revenue Share by Application (2021-2032) Figure 43. North America Liquid Embolic Agent Sales Share by Application (2021-2032) Figure 44. North America Liquid Embolic Agent Revenue Share by Country (2021-2032) Figure 45. North America Liquid Embolic Agent Sales Share by Country (2021-2032) Figure 46. Europe Liquid Embolic Agent Revenue Share by Type (2021-2032) Figure 47. Europe Liquid Embolic Agent Sales Share by Type (2021-2032) Figure 48. Europe Liquid Embolic Agent Revenue Share by Application (2021-2032) Figure 49. Europe Liquid Embolic Agent Sales Share by Application (2021-2032) Figure 50. Europe Liquid Embolic Agent Revenue Share by Country (2021-2032) Figure 51. Europe Liquid Embolic Agent Sales Share by Country (2021-2032) Figure 52. China Liquid Embolic Agent Revenue Share by Type (2021-2032) Figure 53. China Liquid Embolic Agent Sales Share by Type (2021-2032) Figure 54. China Liquid Embolic Agent Revenue Share by Application (2021-2032) Figure 55. China Liquid Embolic Agent Sales Share by Application (2021-2032) Figure 56. Asia Liquid Embolic Agent Revenue Share by Type (2021-2032) Figure 57. Asia Liquid Embolic Agent Sales Share by Type (2021-2032) Figure 58. Asia Liquid Embolic Agent Revenue Share by Application (2021-2032) Figure 59. Asia Liquid Embolic Agent Sales Share by Application (2021-2032) Figure 60. Asia Liquid Embolic Agent Revenue Share by Country (2021-2032) Figure 61. Asia Liquid Embolic Agent Sales Share by Country (2021-2032) Figure 62. SAMEA Liquid Embolic Agent Revenue Share by Type (2021-2032) Figure 63. SAMEA Liquid Embolic Agent Sales Share by Type (2021-2032) Figure 64. SAMEA Liquid Embolic Agent Revenue Share by Application (2021-2032) Figure 65. SAMEA Liquid Embolic Agent Sales Share by Application (2021-2032) Figure 66. SAMEA Liquid Embolic Agent Revenue Share by Country (2021-2032) Figure 67. SAMEA Liquid Embolic Agent Sales Share by Country (2021-2032) Figure 68. Liquid Embolic Agent Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Liquid Embolic Agent Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • EVOH Type
  • nBCA Type
  • Other
Applications
  • Cerebral Arteriovenous Malformations (AVMs)
  • Dural Arteriovenous Fistulas (DAVFs)
  • Other
Companies covered
  • Saikesaisi Holding
  • Johnson & Johnson
  • Medtronic
  • Meril Life
  • BlackSwan Vascular
  • Balt Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liquid Embolic Agent Market by Type
  3. 1.2.1 Global Liquid Embolic Agent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 EVOH Type
  5. 1.2.3 nBCA Type
  6. 1.2.4 Other
  7. 1.3 Liquid Embolic Agent Market by Application
  8. 1.3.1 Global Liquid Embolic Agent Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cerebral Arteriovenous Malformations (AVMs)
  10. 1.3.3 Dural Arteriovenous Fistulas (DAVFs)
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Liquid Embolic Agent Market Dynamics
  1. 2.1 Liquid Embolic Agent Industry Trends
  2. 2.2 Liquid Embolic Agent Industry Drivers
  3. 2.3 Liquid Embolic Agent Industry Opportunities and Challenges
  4. 2.4 Liquid Embolic Agent Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liquid Embolic Agent Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liquid Embolic Agent Revenue by Region
  3. 3.2.1 Global Liquid Embolic Agent Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liquid Embolic Agent Revenue by Region (2021-2026)
  5. 3.2.3 Global Liquid Embolic Agent Revenue by Region (2027-2032)
  6. 3.2.4 Global Liquid Embolic Agent Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liquid Embolic Agent Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liquid Embolic Agent Sales by Region
  9. 3.4.1 Global Liquid Embolic Agent Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liquid Embolic Agent Sales by Region (2021-2026)
  11. 3.4.3 Global Liquid Embolic Agent Sales by Region (2027-2032)
  12. 3.4.4 Global Liquid Embolic Agent Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liquid Embolic Agent Revenue by Manufacturers
  2. 4.1.1 Global Liquid Embolic Agent Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liquid Embolic Agent Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liquid Embolic Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liquid Embolic Agent Sales by Manufacturers
  6. 4.2.1 Global Liquid Embolic Agent Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liquid Embolic Agent Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liquid Embolic Agent Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liquid Embolic Agent Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liquid Embolic Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liquid Embolic Agent Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liquid Embolic Agent Manufacturers, Product Type & Application
  13. 4.7 Global Liquid Embolic Agent Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liquid Embolic Agent Market CR5 and HHI
  16. 4.8.2 2025 Liquid Embolic Agent Tier 1, Tier 2, and Tier 3
5 Liquid Embolic Agent Market by Type
  1. 5.1 Global Liquid Embolic Agent Revenue by Type
  2. 5.1.1 Global Liquid Embolic Agent Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liquid Embolic Agent Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liquid Embolic Agent Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liquid Embolic Agent Sales by Type
  6. 5.2.1 Global Liquid Embolic Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liquid Embolic Agent Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Liquid Embolic Agent Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liquid Embolic Agent Price by Type
6 Liquid Embolic Agent Market by Application
  1. 6.1 Global Liquid Embolic Agent Revenue by Application
  2. 6.1.1 Global Liquid Embolic Agent Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liquid Embolic Agent Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liquid Embolic Agent Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liquid Embolic Agent Sales by Application
  6. 6.2.1 Global Liquid Embolic Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liquid Embolic Agent Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Liquid Embolic Agent Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liquid Embolic Agent Price by Application
7 Company Profiles
  1. 7.1 Saikesaisi Holding
  2. 7.1.1 Saikesaisi Holding Company Information
  3. 7.1.2 Saikesaisi Holding Business Overview
  4. 7.1.3 Saikesaisi Holding Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Saikesaisi Holding Liquid Embolic Agent Product Portfolio
  6. 7.1.5 Saikesaisi Holding Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Liquid Embolic Agent Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Medtronic
  14. 7.3.1 Medtronic Company Information
  15. 7.3.2 Medtronic Business Overview
  16. 7.3.3 Medtronic Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Medtronic Liquid Embolic Agent Product Portfolio
  18. 7.3.5 Medtronic Recent Developments
  19. 7.4 Meril Life
  20. 7.4.1 Meril Life Company Information
  21. 7.4.2 Meril Life Business Overview
  22. 7.4.3 Meril Life Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Meril Life Liquid Embolic Agent Product Portfolio
  24. 7.4.5 Meril Life Recent Developments
  25. 7.5 BlackSwan Vascular
  26. 7.5.1 BlackSwan Vascular Company Information
  27. 7.5.2 BlackSwan Vascular Business Overview
  28. 7.5.3 BlackSwan Vascular Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 BlackSwan Vascular Liquid Embolic Agent Product Portfolio
  30. 7.5.5 BlackSwan Vascular Recent Developments
  31. 7.6 Balt Group
  32. 7.6.1 Balt Group Company Information
  33. 7.6.2 Balt Group Business Overview
  34. 7.6.3 Balt Group Liquid Embolic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Balt Group Liquid Embolic Agent Product Portfolio
  36. 7.6.5 Balt Group Recent Developments
8 North America
  1. 8.1 North America Liquid Embolic Agent Market Size by Type
  2. 8.1.1 North America Liquid Embolic Agent Revenue by Type (2021-2032)
  3. 8.1.2 North America Liquid Embolic Agent Sales by Type (2021-2032)
  4. 8.1.3 North America Liquid Embolic Agent Price by Type (2021-2032)
  5. 8.2 North America Liquid Embolic Agent Market Size by Application
  6. 8.2.1 North America Liquid Embolic Agent Revenue by Application (2021-2032)
  7. 8.2.2 North America Liquid Embolic Agent Sales by Application (2021-2032)
  8. 8.2.3 North America Liquid Embolic Agent Price by Application (2021-2032)
  9. 8.3 North America Liquid Embolic Agent Market Size by Country
  10. 8.3.1 North America Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liquid Embolic Agent Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Liquid Embolic Agent Market Size by Type
  2. 9.1.1 Europe Liquid Embolic Agent Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liquid Embolic Agent Sales by Type (2021-2032)
  4. 9.1.3 Europe Liquid Embolic Agent Price by Type (2021-2032)
  5. 9.2 Europe Liquid Embolic Agent Market Size by Application
  6. 9.2.1 Europe Liquid Embolic Agent Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liquid Embolic Agent Sales by Application (2021-2032)
  8. 9.2.3 Europe Liquid Embolic Agent Price by Application (2021-2032)
  9. 9.3 Europe Liquid Embolic Agent Market Size by Country
  10. 9.3.1 Europe Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liquid Embolic Agent Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Liquid Embolic Agent Market Size by Type
  2. 10.1.1 China Liquid Embolic Agent Revenue by Type (2021-2032)
  3. 10.1.2 China Liquid Embolic Agent Sales by Type (2021-2032)
  4. 10.1.3 China Liquid Embolic Agent Price by Type (2021-2032)
  5. 10.2 China Liquid Embolic Agent Market Size by Application
  6. 10.2.1 China Liquid Embolic Agent Revenue by Application (2021-2032)
  7. 10.2.2 China Liquid Embolic Agent Sales by Application (2021-2032)
  8. 10.2.3 China Liquid Embolic Agent Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liquid Embolic Agent Market Size by Type
  2. 11.1.1 Asia Liquid Embolic Agent Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liquid Embolic Agent Sales by Type (2021-2032)
  4. 11.1.3 Asia Liquid Embolic Agent Price by Type (2021-2032)
  5. 11.2 Asia Liquid Embolic Agent Market Size by Application
  6. 11.2.1 Asia Liquid Embolic Agent Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liquid Embolic Agent Sales by Application (2021-2032)
  8. 11.2.3 Asia Liquid Embolic Agent Price by Application (2021-2032)
  9. 11.3 Asia Liquid Embolic Agent Market Size by Country
  10. 11.3.1 Asia Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liquid Embolic Agent Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liquid Embolic Agent Market Size by Type
  2. 12.1.1 SAMEA Liquid Embolic Agent Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liquid Embolic Agent Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liquid Embolic Agent Price by Type (2021-2032)
  5. 12.2 SAMEA Liquid Embolic Agent Market Size by Application
  6. 12.2.1 SAMEA Liquid Embolic Agent Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liquid Embolic Agent Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liquid Embolic Agent Price by Application (2021-2032)
  9. 12.3 SAMEA Liquid Embolic Agent Market Size by Country
  10. 12.3.1 SAMEA Liquid Embolic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liquid Embolic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liquid Embolic Agent Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liquid Embolic Agent Value Chain Analysis
  2. 13.1.1 Liquid Embolic Agent Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liquid Embolic Agent Production Mode & Process
  6. 13.2 Liquid Embolic Agent Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liquid Embolic Agent Distributors
  9. 13.2.3 Liquid Embolic Agent Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst